BC Cancer
British Columbia's provincial cancer agency, a world leader in cancer genomics (Personalized OncoGenomics), lymphoma research and HPV-based cervical screening.
BC Cancer, part of the Provincial Health Services Authority, delivers cancer care through six regional centres and runs the province's screening programmes and registry. Its Michael Smith Genome Sciences Centre under Marco Marra launched the Personalized OncoGenomics programme in 2012, one of the first to sequence whole genomes and transcriptomes of patients' tumours to guide therapy. Sam Aparicio co-led METABRIC and pioneered single-cell genomics of breast cancer; David Huntsman's OVCARE group discovered ARID1A mutations in clear-cell ovarian cancer; Randy Gascoyne, Christian Steidl and Joseph Connors built one of the world's leading lymphoma programmes, including co-leadership of ECHELON-1 for brentuximab vedotin in Hodgkin lymphoma. Gina Ogilvie's HPV FOCAL trial helped move BC to HPV-based primary cervical screening, and Connie Eaves's Terry Fox Laboratory shaped stem cell biology.
- Personalized OncoGenomics
- Lymphoma
- Ovarian cancer (OVCARE)
- HPV-based cervical screening
- Terry Fox Laboratory
Pages like this
not linked directly; found by shared links- InstitutionCancer Research UK Cambridge Centre / CRUK Cambridge Institute
Shares RNA sequencing & expression profiling, Single-cell & spatial profiling, Whole-exome & whole-genome sequencing, Ovarian cancer.
- TrialKEYNOTE-204
Shares Brentuximab vedotin, Hodgkin lymphoma.
- InstitutionJuravinski Cancer Centre / Escarpment Cancer Research Institute
Shares Canadian Cancer Trials Group (CCTG), Hodgkin lymphoma, HR-positive / HER2-negative breast cancer.
- TrialAETHERA
Shares Brentuximab vedotin, Hodgkin lymphoma.
- InstitutionButaro Cancer Center of Excellence
Shares Hodgkin lymphoma, Cervical cancer, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
- PersonAlex F. Herrera
Shares Brentuximab vedotin, Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- PersonPartha Basu
- InstitutionThe Ottawa Hospital Cancer Centre / Ottawa Hospital Research Institute
Shares Canadian Cancer Trials Group (CCTG), Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.